Researchers at Calviri have discovered a new biomarker in lung cancer patients that could better predict treatment response.
Tag: calviri
Meet Calviri: The PBC company developing a vaccine for cancer
Calviri, Inc. is a Phoenix Bioscience Core-based company is working on a vaccine for cancer – yes, you read that correctly.
PBC Company Calviri announces enrollment of 800 dogs in preventative cancer vaccine trial
Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
Calviri CEO Dr. Stephen Johnston on cancer eradication
Phoenix Bioscience Core-based Calviri Inc.’s founder Dr. Stephen Johnston recently spoke to Progress, Potential and Possibilities on eradicating cancer via a universival preventative cancer vaccine.
Calviri announces new scientific advisory board
The newly formed Scientific Advisory Board will collaborate closely with Calviri’s senior leadership team and support the advancement of the company’s diversified portfolio of diagnostic platforms and therapeutic cancer vaccines pipeline targeting both human and animal health.
Fueling a Bioscience Powerhouse
ASU’s Thrive Magazine features the Phoenix Bioscience Core and its role in driving Phoenix’s life sciences innovation ecosystem.